The CMS Oncology Care Model (OCM) was associated with reduced chemotherapy initiation and lower Medicare spending among ...

Community oncology practices are on the front lines of cancer care innovation, yet they face mounting external pressures that ...

In contrast, allo-HCT offers the potential for long-term disease control through a graft-vs-tumor effect, in which donor ...

COA's annual conference hits Orlando April 28, focusing on AI, targeted therapy innovation, and state-level oncology advocacy ...

Christine Pfaff, RPh, MBA, director of clinical initiatives at the Community Oncology Alliance (COA), sees this year’s ...

Anifrolumab-fnia, an IFNAR1-blocking monoclonal antibody, is now authorized for weekly subcutaneous self-administration in ...

Surveillance captured 16,775 RSV-associated hospitalizations/ED visits; median age was 10 months, with 41% of ...

Radioligand therapy expands patient access in community oncology, pairing precision imaging with safe local delivery so ...

Global MASH cirrhosis burden is rapidly increasing, yet therapeutic and prognostic frameworks remain limited, with sparse ...

Delivering bispecifics and CAR T in community settings could improve access and lower costs but requires robust symptom ...

Emerging research presented at the 2026 American Academy of Dermatology (AAD) Annual Meeting is reinforcing a critical shift ...

A new report shows that physical exercise can lead to numerous benefits for people with chronic kidney disease (CKD), ...